ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Should You Buy the Post-Earnings Dip in Axon Stock or Stay Far, Far Away?

Axon Enterprise's (AXON) stock cratered 9.4% on Wednesday, marking the stock's worst single-day decline since mid-February, after the maker of Tasers and law enforcement software badly missed profit expectations despite posting record quarterly revenue. AXON stock has dropped another 8% during today's trading session.

In Q3 of 2025, Axon reported adjusted earnings per share of $1.17, below estimates of $1.52. The earnings miss was attributed to tariff pressures, which squeezed margins amid rising operating expenses. However, revenue rose 31% to $711 million, above estimates of $705 million. Notably, it was the seventh consecutive quarter where revenue growth exceeded 30%.

 

www.barchart.com

The earnings miss was also tied to margin compression in Axon's connected devices business, which includes Tasers and counter-drone equipment. Adjusted gross margins contracted 50 basis points to 62.7% as tariffs impacted the hardware-heavy segment that generated over $405 million in quarterly revenue. 

Additionally, Axon swung to an operating loss of $2.2 million in Q3, compared to a profit of $24.1 million in the year-ago period, driven by aggressive hiring and stock-based compensation expenses as the company invests heavily in future growth. 

It was Axon’s fourth straight quarter of operating losses despite surging top-line momentum. The company raised its full-year revenue guidance to $2.74 billion, while the midpoint of its adjusted EBITDA guidance for Q4 stood at $180 million, which is below the consensus estimate of $187 million. 

The Bull Case for AXON Stock

The public safety technology leader continues to expand beyond its core Taser and body camera offerings into a comprehensive platform spanning drones, real-time operations, and artificial intelligence (AI) capabilities.

The company's software and services business remains the primary growth driver, surging 41% to $305 million with annual recurring revenue reaching $1.3 billion and a net revenue retention rate of 124%. 

Connected devices revenue grew 24% to $405 million, driven by the adoption of Taser 10, body camera upgrades, and platform solutions, including counter-drone technology. The AI Era Plan, launched in October 2024, has already generated over $200 million in bookings this year, with management expecting AI to contribute more than 10% of U.S. state and local bookings for the full year. 

The bundle includes Draft One automated report writing, which saves officers roughly 11 hours weekly, real-time translation capabilities, and Policy Chat, which provides instant access to department procedures. Year-to-date (YTD) bookings have accelerated more than 30% with management projecting a high 30% growth for the full year.

Axon made significant strategic moves to expand its ecosystem with the acquisitions of Prepared and the pending Carbyne acquisition, valued at $625 million. Together, these companies create what management calls Axon 911, providing AI-powered voice communication automation for emergency call centers alongside cloud-based infrastructure that replaces legacy on-premise systems. 

The 911 platform integrates seamlessly with Fusus' real-time crime centers, body cameras, and drone capabilities to create an end-to-end connected platform, from the initial 911 call through incident response.

International business delivered two of the company's top ten deals in the quarter, including a nine-figure cloud contract in Europe, signaling accelerating adoption beyond traditional markets. 

The corrections segment contributed two additional top-ten deals, with YTD bookings more than doubling. Management emphasized aggressive investment plans across research and development, sales capacity, and emerging categories, including vehicle intelligence, automated license plate readers, and the launch of the Mini enterprise body camera next year, targeting the retail and corporate security markets.

Is AXON Stock Still Overvalued Right Now?

Valued at a market cap of over $50 billion, AXON stock has returned more than 3,500% to shareholders over the past decade. Today, it trades 20% below all-time highs, allowing you to buy the dip. 

Analysts tracking AXON stock forecast revenue to increase from $2.08 billion in 2024 to over $5 billion in 2029. During this period, its free cash flow is predicted to grow from $329.5 million to $1.22 billion by 2029. 

Today, AXON trades at a forward FCF multiple of 69x, which is below the five-year average of 93.6x. If AXON stock trades at a lower multiple of 50x, it should return 20% within the next four years, which is a steady rather than spectacular result. 

Out of the 19 analysts covering AXON stock, 13 recommend “Strong Buy,” three recommend “Moderate Buy,” and three recommend “Hold.” The average AXON stock price target is $871.19, above the current price of $587.21.

www.barchart.com

On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.98
-3.06 (-1.26%)
AAPL  268.93
-0.84 (-0.31%)
AMD  228.54
-9.16 (-3.85%)
BAC  53.02
-0.27 (-0.52%)
GOOG  277.86
-7.48 (-2.62%)
META  609.09
-9.85 (-1.59%)
MSFT  494.74
-2.36 (-0.47%)
NVDA  182.59
-5.49 (-2.92%)
ORCL  234.15
-9.65 (-3.96%)
TSLA  428.72
-17.19 (-3.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.